Oculis Holding AG (OCS) Free Cash Flow (QoQ) (2022 - 2026)
Oculis Holding AG (OCS) Free Cash Flow (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 37.43 Bn | 37.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.99% |
| Dec 31, 2025 | -25.30% |
| Sep 30, 2025 | 19.62% |
| Jun 30, 2025 | 1.91% |
| Mar 31, 2025 | -74.40% |
| Dec 31, 2024 | 1.79% |
| Sep 30, 2024 | 19.01% |
| Jun 30, 2024 | 3.34% |
| Mar 31, 2024 | 1.84% |
| Dec 31, 2023 | -18.26% |
| Sep 30, 2023 | 7.98% |
| Jun 30, 2023 | 12.87% |
| Mar 31, 2023 | -227.46% |
| Dec 31, 2022 | 22.74% |